There is a long story about how Electric Last Mile got their beautiful state of the art manufacturing plant. Another company that left it, I'm so stoned right now I just can't remember. They got a really good deal.
GBA's "2021 Stock Phantasma"
- Thread starter stonedinvestor
- Start date
I know it popped on a CNBC pump, but it IS starting to finally break out.
What if it goes to $16 tomorrow and then channels between today's close and $16 for a bit. You won't jump back in. You wanna see the $13's again. If it is a truly good stock, we won't see the $13's again.
A lot of people have been holding this thing for quite awhile. It was the weak hands that drove it back down on that big move.
If it starts up again, the hardest thing in the world is to buy back in for more than you sold it for. And you know what happens then? You watch from the sidelines as it keeps climbing higher. Trading psychology.
Now not every stock is like this, but in this particular case, this one just might be.
We'll see what happens.
I knew that stock sounded familiar.
Whatever happened to this guy Stoney?
I gave him a like on this post.
But my query as to his whereabouts stems from this one.... I just gave it a like lol.
I doubt if he did, but I hope he held on.
$3000 to $500,000 near the top if he did.
He nailed Tupperware in that thread too.
And hey even though I compared GME to RSH in the post following it.... at least I called out L-Brands @ $16 in the next post.
It's $80 now.
Not a GME, but not bad either.
Last edited:
I know it popped on a CNBC pump, but it IS starting to finally break out.
What if it goes to $16 tomorrow and then channels between today's close and $16 for a bit. You won't jump back in. You wanna see the $13's again. If it is a truly good stock, we won't see the $13's again.
A lot of people have been holding this thing for quite awhile. It was the weak hands that drove it back down on that big move.
If it starts up again, the hardest thing in the world is to buy back in for more than you sold it for. And you know what happens then? You watch from the sidelines as it keeps climbing higher. Trading psychology.
Now not every stock is like this, but in this particular case, this one just might be.
We'll see what happens.
too hard not to sell on a pump ¯\_(ツ)_/¯
I know it popped on a CNBC pump, but it IS starting to finally break out.
What if it goes to $16 tomorrow and then channels between today's close and $16 for a bit. You won't jump back in. You wanna see the $13's again. If it is a truly good stock, we won't see the $13's again.
A lot of people have been holding this thing for quite awhile. It was the weak hands that drove it back down on that big move.
If it starts up again, the hardest thing in the world is to buy back in for more than you sold it for. And you know what happens then? You watch from the sidelines as it keeps climbing higher. Trading psychology.
Now not every stock is like this, but in this particular case, this one just might be.
We'll see what happens.
i'm hanging on tight and really tempted to place a make-or-break-trade if we dip before earnings on Aug 11. i'm thinking OTM calls, maybe the Sept $20 to give myself a little safety net.
- I think WP Carey can be bought again. It's really not that far ahead of where we owned it in the past $69-$79 area))))) Now- $ 80.50. CC today at 10:00
- W.P. Carey(NYSE:WPC)raises its 2021 adjusted FFO guidance as it's confident it can maintain a strong pace of investments in the second half of the year.
- "Our accelerated pace of deal closings during the second quarter brought investment volume for the first half of the year to $1B, driving AFFO growth and putting us on a trajectory to generate record annual deal volume," CEO Jason Fox said.
- The company now sees adjusted FFO per share of $4.94-5.02 from its previous range of $4.87-4.97; compares with Visible Alpha consensus of $4.96.
- The revised guidance includes Real Estate adjusted FFO of $4.82-4.90 vs. its previous range of $4.74-4.84.
- Q2 adjusted FFO per share of $1.27 beats the average analyst estimate of $1.18; increased from $1.22 in Q1.
- Real Estate Segment AFFO per share of $1.23 vs. $1.19 in Q1.
- Real Estate portfolio investment volume of $780.0M brings total investment volume for H1 2021 to $993.7M.
- Real Estate active investments and commitments of $174.4M outstanding at quarter end, including $122.0M scheduled to be completed during H2 2021.
- Overall collection rate was 99% for Q2 2021 rent due and portfolio occupancy stood at 98.0% at quarter-end vs. 98.3% at Q1-end.
- Total company revenue of $319.7M exceeds the $315.0M consensus and increased from $311.2M in Q1.
COVID-19 Delta variant is as contagious as chickenpox, CDC report says - NYT....
Male grooming startup Manscaped is said in talks to go public through SPAC Bright Lights....
In other news a SPAC jumped over a shark.
Male grooming startup Manscaped is said in talks to go public through SPAC Bright Lights....
In other news a SPAC jumped over a shark.
been following this co for a long whiles now--
Optinose completes patient recruitment in trial for XHANCE in chronic sinusitis 08:20 OPTN Optinose announced it has successfully completed recruitment in the first of two pivotal clinical trials to evaluate the safety and efficacy of XHANCE nasal spray as a treatment for patients with chronic sinusitis."The completion of recruitment for this trial keeps us on track to have top-line results in the first quarter of 2022," said CEO Peter Miller. "Approximately 30 million adults in the U.S. suffer from CS and there are no FDA-approved drug treatments for the disease today. If successfully developed, we believe our business potential with XHANCE will expand multi-fold with the new indication in terms of the number of patients who can be reached promotionally, the size of the physician audience that can be productively engaged, and the potential for commercial partnerships."
Optinose completes patient recruitment in trial for XHANCE in chronic sinusitis 08:20 OPTN Optinose announced it has successfully completed recruitment in the first of two pivotal clinical trials to evaluate the safety and efficacy of XHANCE nasal spray as a treatment for patients with chronic sinusitis."The completion of recruitment for this trial keeps us on track to have top-line results in the first quarter of 2022," said CEO Peter Miller. "Approximately 30 million adults in the U.S. suffer from CS and there are no FDA-approved drug treatments for the disease today. If successfully developed, we believe our business potential with XHANCE will expand multi-fold with the new indication in terms of the number of patients who can be reached promotionally, the size of the physician audience that can be productively engaged, and the potential for commercial partnerships."
Restaurant Brands approves $1B share repurchase authorization 07:58 QSR The RBI board of directors has declared a dividend of 53c per common share and partnership exchangeable unit of Restaurant Brands International Limited Partnership for the second quarter of 2021. The dividend will be payable on October 5 to shareholders and unitholders of record at the close of business on September 21. The board of directors also approved a share repurchase authorization that allows the repurchase of up to $1B of its common shares over the next two years. "We plan to submit a new normal course issuer bid, subject to TSX approval, to be effective following expiration of the current one," the company said. Jose Cil, CEO of Restaurant Brands International, added: "We also announced an increase in our share buyback authorization to $1 billion over the next two years, demonstrating our confidence in the value creation opportunity we have ahead of us with our three iconic brands, scalable business model, expanding digital strength and dedicated franchise partners. We believe we are well positioned to drive sustainable, long-term sales growth across the business and to continue enhancing shareholder returns with significant returns of capital through our industry-leading dividend and opportunistic share buybacks under our newly expanded authorization."
Welcome to the $100 club.
LyondellBasell reports Q2 EPS $6.13, consensus $5.11 06:34 LYB Reports Q2 revenue $11.56B, consensus $10.74B. Reports record quarterly adjusted EBITDA of $3B. "LyondellBasell's outstanding results demonstrate that our company continues to be well positioned to benefit from the ongoing global economic recovery. Persistent consumer and industrial demand enabled us to establish new benchmarks for profitability during the second quarter. In both of our Olefins and Polyolefins segments, strong demand supported price and margin improvements resulting in record quarterly EBITDA. Reopening and increased mobility are driving higher demand for transportation fuels and improving margins for our Oxyfuels and Refining businesses. During the period, we operated all of our available capacity near full rates to begin rebuilding depleted inventories and addressing our customers' backlogs," said Bob Patel, LyondellBasell CEO.
LyondellBasell reports Q2 EPS $6.13, consensus $5.11 06:34 LYB Reports Q2 revenue $11.56B, consensus $10.74B. Reports record quarterly adjusted EBITDA of $3B. "LyondellBasell's outstanding results demonstrate that our company continues to be well positioned to benefit from the ongoing global economic recovery. Persistent consumer and industrial demand enabled us to establish new benchmarks for profitability during the second quarter. In both of our Olefins and Polyolefins segments, strong demand supported price and margin improvements resulting in record quarterly EBITDA. Reopening and increased mobility are driving higher demand for transportation fuels and improving margins for our Oxyfuels and Refining businesses. During the period, we operated all of our available capacity near full rates to begin rebuilding depleted inventories and addressing our customers' backlogs," said Bob Patel, LyondellBasell CEO.